Top 10 Emerging Travel Vaccine Firms in Japan 2026

User avatar placeholder
Written by Robert Gultig

5 January 2026

Introduction:

The global travel vaccine market is expected to witness significant growth in the coming years, with a particular focus on emerging firms in Japan. With the increasing emphasis on global health and the rise in international travel, the demand for travel vaccines is on the rise. According to industry reports, the global travel vaccine market is projected to reach a value of $5.1 billion by 2026.

Top 10 Emerging Travel Vaccine Firms in Japan 2026:

1. JCR Pharmaceuticals Co., Ltd.
JCR Pharmaceuticals Co., Ltd. is a leading biopharmaceutical company in Japan specializing in the development and production of vaccines. With a strong focus on research and development, the company has seen a significant increase in market share in recent years.

2. Daiichi Sankyo Company, Limited
Daiichi Sankyo Company, Limited is a multinational pharmaceutical company based in Japan, known for its innovative vaccine products. The company has been expanding its presence in the travel vaccine market and is expected to be a key player in the coming years.

3. Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited is one of the largest pharmaceutical companies in Japan, with a strong portfolio of vaccines for various diseases. The company has been investing heavily in research and development of travel vaccines, positioning itself as a top player in the market.

4. Astellas Pharma Inc.
Astellas Pharma Inc. is a global pharmaceutical company headquartered in Japan, with a growing presence in the travel vaccine market. The company’s commitment to innovation and quality has helped it gain a competitive edge in the industry.

5. Mitsubishi Tanabe Pharma Corporation
Mitsubishi Tanabe Pharma Corporation is a leading pharmaceutical company in Japan, with a focus on developing vaccines for infectious diseases. The company’s strong pipeline of travel vaccines is expected to drive its growth in the coming years.

6. Eisai Co., Ltd.
Eisai Co., Ltd. is a research-based pharmaceutical company in Japan, known for its contributions to the development of vaccines. The company’s investment in travel vaccine research has positioned it as a key player in the market.

7. Shionogi & Co., Ltd.
Shionogi & Co., Ltd. is a Japanese pharmaceutical company with a strong focus on infectious disease vaccines. The company’s commitment to quality and innovation has helped it gain a significant market share in the travel vaccine segment.

8. Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd. is a leading pharmaceutical company in Japan, with a diverse portfolio of vaccines for various diseases. The company’s strong presence in the travel vaccine market is expected to drive its growth in the coming years.

9. Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical Co., Ltd. is a research-based pharmaceutical company in Japan, known for its innovative vaccine products. The company’s focus on research and development has helped it gain a competitive edge in the travel vaccine market.

10. Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd. is a global pharmaceutical company headquartered in Japan, with a strong presence in the travel vaccine segment. The company’s commitment to quality and innovation has positioned it as a top player in the market.

Insights:

The emerging travel vaccine firms in Japan are expected to play a significant role in shaping the global market in the coming years. With a focus on innovation and quality, these companies are well-positioned to meet the growing demand for travel vaccines. According to industry analysts, the travel vaccine market is projected to grow at a CAGR of 8.5% from 2021 to 2026, reaching a value of $5.1 billion. As international travel continues to increase, the importance of travel vaccines in preventing the spread of infectious diseases cannot be understated. The top 10 emerging travel vaccine firms in Japan are poised to make a significant impact on the market and drive growth in the years to come.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →